Showing results (151-160 of 181) with videos related to
Sort By:
Pageof 19
Haematologica|January 14, 2011
Overexpression of Enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapyDaisuke Sasaki, Yoshitaka Imaizumi, Hiroo Hasegawa, et al.Blood|November 26, 2011
Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cellsShan He, Jina Wang, Koji Kato, et al.Nature|January 29, 2015
EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitorsChristine M Fillmore, Chunxiao Xu, Pooja T Desai, et al.Plos Pathogens|July 28, 2010
Epigenetic analysis of KSHV latent and lytic genomesZsolt Toth, Dennis T Maglinte, Sun Hwa Lee, et al.Cancer Research|November 26, 2009
EZH2 is essential for glioblastoma cancer stem cell maintenanceMario-Luca Suvà, Nicolò Riggi, Michalina Janiszewska, et al.Nature|September 26, 2018
Author Correction: EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitorsChristine M Fillmore, Chunxiao Xu, Pooja T Desai, et al.Clinical Epigenetics|August 8, 2015
MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcomaSerena Vella, Silvia Pomella, Pier Paolo Leoncini, et al.The Journal of Biological Chemistry|June 1, 2005
A novel diacylglycerol-lactone shows marked selectivity in vitro among C1 domains of protein kinase C (PKC) isoforms alpha and delta as well as selectivity for RasGRP compared with PKCalphaYongmei Pu, Nicholas A Perry, Dazhi Yang, et al.Gastroenterology|February 12, 2013
Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatinChi Han Li, Ka-Fai To, Joanna Hung-Man Tong, et al.The Journal of Biological Chemistry|September 1, 2006
Effect of DNA modifications on DNA processing by HIV-1 integrase and inhibitor binding: role of DNA backbone flexibility and an open catalytic siteAllison A Johnson, Jane M Sayer, Haruhiko Yagi, et al.Pageof 19